Intravirion display of a peptide corresponding to the dimer interface structure of protease attenuates HIV-1 replication

DNA and Cell Biology

Volumn 20, Issue 12, 2002, Pages 797-805

  Cartas, M ^a   Singh, S P ^a   Serio, D ^a   Rizvi, T A ^b   Kalyanaraman, V S ^c   Goldsmith, C S ^d   Zaki, S R ^d   Weber, I T ^e   Srinivasan, A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHIMERIC PROTEIN; DNA; PROTEINASE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRION; VIRUS ASSEMBLY; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION; WILD TYPE;

ANTI-HIV AGENTS; BASE SEQUENCE; CELL LINE; GENE PRODUCTS, VPR; HIV PROTEASE; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; RADIOIMMUNOPRECIPITATION ASSAY; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036182035     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454901753438615     Document Type: Article

References (37)

1. Production of acquired immunodeficiency-associated retrovirus in human and non human cells transfected with an infectious molecular clone
2. Synthetic "interface" peptides alter dimeric assembly of the HIV-1 and 2 proteases
3. Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2
4. HIV-1 auxiliary proteins: Making connections in a dying cell
5. The HIV-1 protease as a therapeutic target for AIDS
6. Specific inhibition of herpes simplex virus DNA polymerase by helical peptides corresponding to the subunit interface
7. Inhibition of human immunodeficiency type-1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain
8. Gene therapy for human immunodeficiency virus infection: Genetic antiviral strategies and targets for intervention
9. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides
10. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
11. HIV-1, Vpr and the cell cycle
12. Complementation of integrase function in HIV-1 virion
13. Macromolecular interactions in the assembly of HIV and other retroviruses
14. The activity of the protease of human immunodeficiency type-1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency
15. Human immunodeficiency virus type-1 Gag proteins are processed in two cellular compartments
16. The retroviral enzymes
17. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line based on activation of an integrated β-galactosidase gene
18. Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins
19. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity
20. Mutagenesis of the putative α-helix domain of the Vpr protein of human immunodeficiency virus type-1: Effect on stability and virion incorporation
21. Closing in on human immunodeficiency virus type 1
22. New antiviral strategy using capsid-nuclease fusion proteins
23. Production of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral integrase
24. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
25. Mutations in retroviral genes associated with drug resistance
26. The inhibition of HIV-1 protease by interface peptides
27. HIV-1 reproduction is inhibited by peptides derived from the N-and C-termini of HIV-1 protease
28. Development of a novel anti-HIV-1 agent from within: Effect of chimeric Vpr containing protease cleavage site residues on virus replication
29. The many ways to cross the plasma membrane
30. Comparison of the crystal structures and inter-subunit interactions of human immunodeficiency and Rous sarcoma virus proteases
31. Human immunodeficiency virus type-1 Nef protein is incorporated into virus particles and is specifically cleaved by the viral protease
32. Form, function, and use of retroviral gag proteins
33. Conserved folding in retroviral protease: Crystal structure of a synthetic HIV-1 protease
34. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease mutant fusion protein into virus particles
35. Dissociative inhibition of dimeric enzymes: Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide